Home » Newsletters » BioWorld Science

BioWorld Science

May 21, 2010

View Archived Issues

Updates on ADX-10059 for clinical management of GERD

TOL-101 antibody modulates T-cell responses in vitro and in vivo

Diannexin reduces ischemia/reperfusion injury in renal transplant recipients

Zydus-Cadila claims new thyroid hormone receptor beta ligands

Alimentary Health presents new immunomodulatory agents

Novel Pot1 inhibitors claimed by French researchers

Metabolex describes new GPR120 agonists for type 2 diabetes

CNRS researchers describe novel antibacterial agents

GSK's high-throughput screen reveals potent antimalarial leads

Dofetilide shows clinical potential for treatment of persistent AF

Lytix obtains Swedish approval for Lytixar phase I/IIa trial in nasal MRSA infection

Revotar reports phase IIa data on bimosiamose in COPD

InVasc Therapeutics receives two phase I SBIR grants

Hawthorn acquires license to anticancer antibodies from University of Pittsburgh

Ad5.SSTR/TK.RGD/ganciclovir active in phase I trial in gynecologic cancer

Pharming initiates divestment of DNage in refocusing effort

Galapagos initiates clinical studies of GLPG-0492 for cachexia

Evotec and Boehringer Ingelheim pain collaboration advances into the clinic

Discovery Labs completes revalidation required for potential approval of Surfaxin in RDS

NexMed to meet with FDA on phase II/III alprostadil trial protocol in Raynaud's syndrome

GAP-107B8 active against ovarian cancer

NORD recognizes Acorda's efforts in multiple sclerosis research

CYT003-QbG10 demonstrates efficacy in allergic asthma

Ablynx and Pfizer extend anti-TNF-alpha Nanobody research collaboration

Vaxon's Vx-001 to advance from phase I/II to phase III in NSCLC

Labopharm and Angelini group complete joint venture for U.S. Oleptro launch

Victory and MiddleBrook Pharma sign asset purchase agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...